Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Magnetic Resonance Imaging Scanners Market
The global Magnetic Resonance Imaging (MRI) Scanners market was valued at USD 10,000 Million in 2025 and is projected to reach USD 18,771.37 Million by 2035, expanding at a CAGR of 6.5% over the forecast period.
Market size
Growth trajectory through 2035
Magnetic Resonance Imaging Scanners Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01
- [data not available in current sources]: [data not available in current sources].
-
Development 02
- [data not available in current sources]: [data not available in current sources].
-
Development 03
- [data not available in current sources]: [data not available in current sources].
Emerging opportunities added
- Portable and low-field MRI systems Development of mobile and low-field MRI solutions addresses accessibility challenges in remote and underserved areas, creating new market segments.
- Integration with AI and machine learning AI-driven image analysis and workflow optimization tools enhance diagnostic efficiency, offering differentiation opportunities for vendors.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $10.00 Bn
- CAGR
- 6.50%
- Expansion
- 1.9×
Market shape
top segment · 100.0% share
- Leading region
- North America
- Top-5 concentration
- Low · ~35%
Forces at play
▲ top tailwind
- ▼ headwind
- High capital and operational costs
- Named players
- 22 profiled
- Growth peak
- 2027–2031
Latest development
[data not available in current sources]: [data not available in current sources]
+2 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 129-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Magnetic Resonance Imaging Scanners Market today ($10.00 Bn base), and how fast will it grow at 6.5% CAGR through 2035?
- Which of Low-to-mid-field MRI systems (0.5T to 1.5T, High-field MRI systems (1.5T to 3T, Very-high-field MRI systems (3T to 7T and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Neurology, Musculoskeletal, Oncology applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Thermo Fisher Scientific, Danaher Corporation, Roche Diagnostics and 19 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Rising prevalence of chronic diseases) and top restraints (led by High capital and operational costs), with quantified CAGR impact?
- What regulatory shifts and 3 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Rising prevalence of chronic diseases The increasing incidence of neurological, musculoskeletal, and oncological conditions necessitates frequent and precise diagnostic imaging, supporting demand for MRI scanners.
- Technological advancements in MRI systems Innovations such as higher field strength systems and improved image resolution enhance diagnostic accuracy, driving adoption among healthcare providers.
- Expansion of healthcare infrastructure in emerging markets Growth in hospital networks and diagnostic centers, particularly in Asia-Pacific and Latin America, creates new demand for MRI equipment.
Restraints
Holding it back
- High capital and operational costs The substantial upfront investment required for MRI systems and associated maintenance expenses limits adoption, especially in resource-constrained settings.
- Stringent regulatory requirements Compliance with evolving safety and performance standards increases development timelines and costs for manufacturers.
- Shortage of skilled professionals The need for trained radiologists and technicians to operate MRI systems constrains market growth in regions with limited access to specialized personnel.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising prevalence of chronic diseases | +2.9% | Global | 2025–2035 |
| Technological advancements in MRI systems | +1.8% | Global | 2025–2035 |
| Expansion of healthcare infrastructure in emerging markets | +1.4% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High capital and operational costs | −1.2% | Global | 2025–2029 |
| Stringent regulatory requirements | −0.8% | Global | 2025–2029 |
| Shortage of skilled professionals | −0.6% | Global | 2025–2029 |
The MRI scanners market is segmented by field strength, application, end user, and region. Field strength categories include low-to-mid-field (0.5T to 1.5T), high-field (1.5T to 3T), very-high-field (3T to 7T), and ultra-high-field (7T and above) systems.
Revenue share by type · 2025 base year
% OF $10.00 BN MAGNETIC RESONANCE IMAGING SCANNERS MARKET · 1 TYPES COVERED
Each slice = that type's share of the total $10.00 Bn Magnetic Resonance Imaging Scanners Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Low-to-mid-field MRI systems (0.5T to 1.5T
-
High-field MRI systems (1.5T to 3T
-
Very-high-field MRI systems (3T to 7T
-
Ultra-high-field MRI systems (7T
-
above
By application
-
Neurology
-
Musculoskeletal
-
Oncology
-
Cardiovascular
-
Other Applications
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $10.00 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~35.8% in 2025. The region leads in market share due to advanced healthcare infrastructure, high adoption of premium MRI systems, and strong reimbursement policies
Per-region detail
-
North America
The region leads in market share due to advanced healthcare infrastructure, high adoption of premium MRI systems, and strong reimbursement policies
-
Europe
Growth is driven by increasing healthcare spending, regulatory support for medical imaging, and demand for high-field MRI systems in major markets such as Germany and the UK
-
Asia-Pacific
Rapid urbanization, expanding private healthcare networks, and government initiatives to improve diagnostic access contribute to the highest CAGR globally
-
Latin America
Market expansion is supported by rising healthcare investments and partnerships with international vendors to improve imaging capabilities in public and private sectors
-
Middle East & Africa
Growth is constrained by economic factors but supported by initiatives to enhance healthcare infrastructure and partnerships with global medical technology providers
Competitive landscape
Who's competing, and how
The market is Low concentration. 22 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The MRI scanners market is moderately concentrated, with a mix of multinational corporations and specialized imaging technology providers competing on innovation, pricing, and service quality.
Concentration snapshot
Top 5 players control 35.0% of the market
Aggregate 2025 share of the top 5 named players (real market share data). Individual company shares in the full report.
Competitive tiers
Players are bucketed by base-year market share: Leaders ≥ 7%, Challengers 3–7%, Emerging < 3%. Full tier rationale + revenue estimates in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Johnson & Johnson · Merck · Novartis
Tier 2 · Challengers
4companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Roche · AbbVie · Eli Lilly · AstraZeneca
Tier 3 · Emerging
15companies
Niche or early-stage, differentiated technology or early-mover positioning.
Thermo Fisher Scientific · Danaher Corporation · Roche Diagnostics · Abbott Diagnostics · Siemens Healthineers
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Thermo Fisher Scientific
Rank 01Share est. ~13%Revenue $■■■MHQ ■■■ -
Danaher Corporation
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Roche Diagnostics
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Abbott Diagnostics
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Siemens Healthineers
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Bio-Rad Laboratories
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
QIAGEN N.V
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Hologic Inc
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 14 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
• What is the market size for the magnetic resonance imaging scanners market?
The global magnetic resonance imaging scanners market is projected to grow from USD 8.15 Billion in 2026 to USD 12.72 Billion by 2035, expanding at a CAGR of 4.15% during the forecast period.
-
• Which region is dominating in the magnetic resonance imaging scanners market?
Asia-Pacific accounted for the largest market in the magnetic resonance imaging scanners market. Asia-Pacific accounted for 40 % market share of the global market value.
-
• Who are the major key players in the magnetic resonance imaging scanners market?
Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Bruker Corporation, Esaote SpA, Fonar Corporation, Mindray Medical International Limited, Neusoft Medical Systems Co., Ltd., Samsung Medison Co., Ltd., Shenzhen Anke High-tech Co., Ltd., Time Medical Systems Co., Ltd., AllTech Medical Systems America, Inc., Aspect Imaging Ltd., Aurigin Technology Inc., CMR Naviscan Corporation, Cubresa Inc., Mediso Ltd., MR Solutions Ltd.
-
• What are the key trends in the magnetic resonance imaging scanners market?
Key trends in the magnetic resonance imaging (MRI) scanners market include the growing adoption of artificial intelligence (AI) for enhanced imaging interpretation, the development of more compact and portable MRI scanners for increased accessibility, and a focus on advanced applications such as functional MRI (fMRI) for neurological studies and precision medicine. Additionally, there is a continuous emphasis on improving patient comfort and experience during MRI examinations.
The Magnetic Resonance Imaging Scanners Market is projected to reach $18.77 Bn by 2035, up from $10.00 Bn in 2025 — a 6.50% CAGR equating to roughly 1.9× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.